PREDICTING TREATMENT RESPONSE IN YOUTH DEPRESSION WITH BRAIN IMAGING

Grant number: 1064643 | Funding period: 2014 - 2018

Completed

Abstract

Depression is the single greatest cause of disability and morbidity in young people. In order to reduce its substantial burden on individuals and society, there is a need to optimise the early provision of existing treatments. In this study, we will use cutting-edge neuroimaging technology to identify “biomarkers” in the brain that will help to more accurately determine which available treatments are likely to be most effective and safe for an individual patient.

Related publications (5)

Neurodevelopmental correlates of proneness to guilt and shame in adolescence and early adulthood

Sarah Whittle, Kirra Liu, Coralie Bastin, Ben J Harrison, Christopher G Davey

2016-06-01

Mapping the self in the brain's default mode network

Christopher G Davey, Jesus Pujol, Ben J Harrison

2016-05-15

Brain Functional Correlates of Emotion Regulation Across Adolescence and Young Adulthood

Katerina Stephanou, Christopher G Davey, Rebecca Kerestes, Sarah Whittle, Jesus Pujol, Murat Yuecel, Alex Fornito, Marina Lopez-Sola, Ben J Harrison

2016-01-01

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial

Christopher G Davey, Andrew M Chanen, Sue M Cotton, Sarah E Hetrick, Melissa J Kerr, Michael Berk, Olivia M Dean, Kally Yuen, Mark Phelan, Aswin Ratheesh, Miriam R Schaefer, G Paul Amminger, Alexandra G Parker, Danijela Piskulic, Susy Harrigan, Andrew J Mackinnon, Ben J Harrison, Patrick D McGorry

2014-11-04